Results 261 to 270 of about 341,992 (364)

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis   +5 more
wiley   +1 more source

Dynamics of hyperglycemia of patients treated with alpelisib: exploratory interim analysis of ITACA trial. [PDF]

open access: yesOncologist
Pancirov M   +8 more
europepmc   +1 more source

1379 RATES AND ASSOCIATED RISK FACTORS FOR DLOW INDUCED HYPERGLYCEMIA (HG) IN NEONATES [PDF]

open access: bronze, 1981
Allen A. Mitchell   +5 more
openalex   +1 more source

Early detection of cerebrospinal fluid/serum glucose ratio: A promising value for mortality prognosis in patients with acute bacterial meningitis

open access: yesJournal of General and Family Medicine, EarlyView.
This study revealed that a glucometer‐based measurement significantly improved the turnaround time required for CSF/serum glucose ratio measurement compared to conventional laboratory tests, which could be considered a reliable aid to the mortality prognosis.
Nasrin Khodashenas   +3 more
wiley   +1 more source

Mechanisms and therapeutic opportunities in metabolic aberrations of diabetic wounds: a narrative review. [PDF]

open access: yesCell Death Dis
Xiong Y   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy